T21 Pill - white oval
Pill with imprint T21 is White, Oval and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Risedronate is used in the treatment of Paget's Disease; Prevention of Osteoporosis; Osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for T21
Risedronate Sodium Delayed-Release
- Imprint
- T21
- Strength
- 35 mg
- Color
- White
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc
- National Drug Code (NDC)
- 00093-5509 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
edetate disodium,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
polysorbate 80,
sodium starch glycolate type A potato,
stearic acid,
magnesium silicate,
triethyl citrate
Note: Inactive ingredients may vary.
Related images for "T21"
More about risedronate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (79)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: bisphosphonates
- Breastfeeding
- En español
Patient resources
- Risedronate drug information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.